An Open-label Study of XEN1101 in Epilepsy

Clinical trial NCT05718817 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05718817
Sponsor: Xenon Pharmaceuticals Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Focal Epilepsy Tonic-Clonic Seizures

Start date: 2023-04-25
Primary completion: 2033-04-01
Enrollment: 880

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.